Literature DB >> 2088207

Effect of the estrous cycle on susceptibility of female mice to intravaginal inoculation of herpes simplex virus type 2 (HSV-2).

A G Teepe1, L B Allen, R J Wordinger, E F Harris.   

Abstract

In order to explore the effect of sexual maturity on the susceptibility of mice to genital herpesvirus infections, mice were separated into the four stages of the estrous cycle and inoculated intravaginally with varying doses of HSV-2, strain 186. Deaths were observed as indicators of susceptibility and were recorded as follows: proestrous, 33%; estrous, 16%; metestrous, 9% and diestrous, 75%. To determine the course of infection in animals inoculated at different stages of estrous, cotton swabs were used to collect vaginal specimens at various times post-virus inoculation for virus titration. All mice inoculated during diestrous were positive for virus as early as 6 hours post-virus inoculation and had titers that increased over a 3 day period. Mice inoculated in other stages of estrus were positive only briefly (at 6 h) or had no detectable virus. In order to verify the susceptibility associated with diestrous, mice were ovariectomized to produce a continuous diestrous (pseudodiestrous) and when inoculated greater than or equal to 66.7% died. In contrast, none of the mice which had been ovariectomized and treated with estrogen to simulate the estrus stage died. We postulate that in stages other than diestrous virus may adsorb to epithelial cells in the lumen of the vagina and/or be expelled from the body by nonspecific resistance functions, thus reducing the likelihood of vaginal infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088207     DOI: 10.1016/0166-3542(90)90004-q

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  11 in total

1.  Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2.

Authors:  E L Parr; M B Parr
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Authors:  Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

3.  Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina.

Authors:  C R Wira; R M Rossoll
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

4.  Estradiol improves genital herpes vaccine efficacy in mice.

Authors:  Jeffry W Pennock; Rachael Stegall; Brent Bell; Gracie Vargas; Massoud Motamedi; Gregg Milligan; Nigel Bourne
Journal:  Vaccine       Date:  2009-08-04       Impact factor: 3.641

5.  Progesterone increases susceptibility and decreases immune responses to genital herpes infection.

Authors:  Charu Kaushic; Ali A Ashkar; Lesley A Reid; Kenneth L Rosenthal
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.

Authors:  Flavia Chiuppesi; Laura Vannucci; Anna De Luca; Michele Lai; Barbara Matteoli; Giulia Freer; Roberto Manservigi; Luca Ceccherini-Nelli; Fabrizio Maggi; Mauro Bendinelli; Mauro Pistello
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

7.  Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.

Authors:  Amy E Gillgrass; Ali A Ashkar; Kenneth L Rosenthal; Charu Kaushic
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 8.  Influence of ovarian hormones on urogenital infection.

Authors:  C Sonnex
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

9.  Interferon lambda protects the female reproductive tract against Zika virus infection.

Authors:  Elizabeth A Caine; Suzanne M Scheaffer; Nitin Arora; Konstantin Zaitsev; Maxim N Artyomov; Carolyn B Coyne; Kelle H Moley; Michael S Diamond
Journal:  Nat Commun       Date:  2019-01-17       Impact factor: 14.919

Review 10.  The Mouse Papillomavirus Infection Model.

Authors:  Jiafen Hu; Nancy M Cladel; Lynn R Budgeon; Karla K Balogh; Neil D Christensen
Journal:  Viruses       Date:  2017-08-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.